CD8A and neoplasm: Antibody depletion experiments in 4T1-bearing mice treated with Nucl-TAP have shown that tumor inhibition was dependent on CD4+, CD8+, as well as on NK cells (Fig. 4a), the latter likely due to the reduced MHC class Ia expression resulting from TAP downregulation (Fig. 2b–d).